Matches in SemOpenAlex for { <https://semopenalex.org/work/W4313384397> ?p ?o ?g. }
Showing items 1 to 66 of
66
with 100 items per page.
- W4313384397 endingPage "82.40" @default.
- W4313384397 startingPage "82.40" @default.
- W4313384397 abstract "Abstract BACKGROUND Genetic engineering pig models of pig-to-human xenotransplantation may overcome a growing shortage of available solid organs. Development of pigs deficient in galactose α1,3 galactose and N-glycolylneuraminic acid have significantly improved cell survival when challenged by human antibody and complement in vitro. The b4GalNT2 glycosyltransferase may also synthesize xenoantigens in pigs. In this study, we used RBC, as a cell model, to assess human antibody-mediated response to non-SLA xenoantigens of pigs deficient in these carbohydrate-modifying genes. MATHODS AND MATERIALS RBC were isolated from wild type pigs and pigs deficient in GGTA1/CMAH knockout (DKO) and GGTA1/CMAH/β4GalNT2 knockout (TKO). Human ABO sera were purchased from Valley Biomedical. Human ABO RBC were isolated from healthy people. Total antibody binding was assessed by hemagglutination assay; human IgG or IgM binding to RBC was characterized by flow cytometry; opsonized RBC phagocytosis by THP-1 macrophages was analyzed using confocal microscope. RESULTS Phenotype of TKO RBC was characterized by flow cytometry. Silencing the three genes reduced hemagglutination levels of TKO RBC compared with that of DKO RBC by all three human blood-type A, O, and AB sera but except blood-type B sera, and decreased both of IgG and IgM binding to TKO RBC compared with DKO RBC. Confocal image data showed that phagocytosis of opsonized TKO RBC was lower than that of opsonized DKO RBC by THP-1 cells. DISCUSSION Non-SLA xenoantigenicity of pig RBC can be disrupted using gene engineering tools, which greatly reduced the humoral barrier to xenotransplantation" @default.
- W4313384397 created "2023-01-06" @default.
- W4313384397 creator A5001265747 @default.
- W4313384397 creator A5016948903 @default.
- W4313384397 creator A5057968924 @default.
- W4313384397 creator A5075124399 @default.
- W4313384397 date "2017-05-01" @default.
- W4313384397 modified "2023-09-25" @default.
- W4313384397 title "Characterization of human preformed antibodies to non-SLA xenoantigens on RBC from genetically-engineering pigs" @default.
- W4313384397 doi "https://doi.org/10.4049/jimmunol.198.supp.82.40" @default.
- W4313384397 hasPublicationYear "2017" @default.
- W4313384397 type Work @default.
- W4313384397 citedByCount "0" @default.
- W4313384397 crossrefType "journal-article" @default.
- W4313384397 hasAuthorship W4313384397A5001265747 @default.
- W4313384397 hasAuthorship W4313384397A5016948903 @default.
- W4313384397 hasAuthorship W4313384397A5057968924 @default.
- W4313384397 hasAuthorship W4313384397A5075124399 @default.
- W4313384397 hasConcept C141071460 @default.
- W4313384397 hasConcept C153911025 @default.
- W4313384397 hasConcept C159654299 @default.
- W4313384397 hasConcept C160448771 @default.
- W4313384397 hasConcept C176080213 @default.
- W4313384397 hasConcept C203014093 @default.
- W4313384397 hasConcept C2776557347 @default.
- W4313384397 hasConcept C2778442404 @default.
- W4313384397 hasConcept C2911091166 @default.
- W4313384397 hasConcept C34343649 @default.
- W4313384397 hasConcept C553184892 @default.
- W4313384397 hasConcept C71924100 @default.
- W4313384397 hasConcept C86803240 @default.
- W4313384397 hasConcept C8891405 @default.
- W4313384397 hasConceptScore W4313384397C141071460 @default.
- W4313384397 hasConceptScore W4313384397C153911025 @default.
- W4313384397 hasConceptScore W4313384397C159654299 @default.
- W4313384397 hasConceptScore W4313384397C160448771 @default.
- W4313384397 hasConceptScore W4313384397C176080213 @default.
- W4313384397 hasConceptScore W4313384397C203014093 @default.
- W4313384397 hasConceptScore W4313384397C2776557347 @default.
- W4313384397 hasConceptScore W4313384397C2778442404 @default.
- W4313384397 hasConceptScore W4313384397C2911091166 @default.
- W4313384397 hasConceptScore W4313384397C34343649 @default.
- W4313384397 hasConceptScore W4313384397C553184892 @default.
- W4313384397 hasConceptScore W4313384397C71924100 @default.
- W4313384397 hasConceptScore W4313384397C86803240 @default.
- W4313384397 hasConceptScore W4313384397C8891405 @default.
- W4313384397 hasIssue "1_Supplement" @default.
- W4313384397 hasLocation W43133843971 @default.
- W4313384397 hasOpenAccess W4313384397 @default.
- W4313384397 hasPrimaryLocation W43133843971 @default.
- W4313384397 hasRelatedWork W1572283981 @default.
- W4313384397 hasRelatedWork W2043102218 @default.
- W4313384397 hasRelatedWork W2078023809 @default.
- W4313384397 hasRelatedWork W2086419350 @default.
- W4313384397 hasRelatedWork W2096567785 @default.
- W4313384397 hasRelatedWork W2115483140 @default.
- W4313384397 hasRelatedWork W2419289023 @default.
- W4313384397 hasRelatedWork W3048051248 @default.
- W4313384397 hasRelatedWork W81185494 @default.
- W4313384397 hasRelatedWork W2886506501 @default.
- W4313384397 hasVolume "198" @default.
- W4313384397 isParatext "false" @default.
- W4313384397 isRetracted "false" @default.
- W4313384397 workType "article" @default.